Novel MRI coil technology for safe imaging of children with implants
Project Number5R01EB034377-02
Contact PI/Project LeaderGOLESTANI RAD, LALEH
Awardee OrganizationNORTHWESTERN UNIVERSITY AT CHICAGO
Description
Abstract Text
Abstract
Magnetic resonance imaging (MRI) has revolutionized our approach to understanding human biology and
pathology. Despite continuous advances, however, MRI remains largely inaccessible to a sizeable and growing
group of patients who have conductive implants. The problem is exacerbated in children, for whom MR-
conditional devices are not readily available, leaving this vulnerable population unable to receive the standard of
care that they need the most, and excluding them from scientific inquiries when they are most advantageous.
The major risk of MRI in patients with conductive implants is the RF heating of the tissue due to the antenna
effect. This happens when the electric field of MRI scanner couples with the implanted device and amplifies the
specific absorption rate (SAR) of the radiofrequency energy in the tissue surrounding the implant. MR-conditional
implants have been approved by the FDA for adults, allowing patients to receive MRI under restricted conditions
that assure safety. Regrettably, however, neither MRI vendors nor device manufacturers have established safe
MRI methodologies for children with conductive implants.
We propose to develop, validate, and deploy a novel multi-platform MRI coil technology that allows ultra-fast and
high-resolution MRI to be safely performed in children with conductive implants regardless of the implant location
in their bodies. Our solution is based on the idea that through innovative engineering we can control local electric
fields generated by MRI on a case-by-case basis, thus avoiding interactions with the individual's implanted
device wherever it happens to be in the body. Our preliminary results show that this technique can achieve a 20-
fold reduction in RF heating of cardiac implantable electronic devices (CEIDs), as well as implants of central
nervous system (CNS) such as EcoG electrodes and Vagus Nerve Stimulation (VNS) devices. Such reduction
in RF heating is sufficient to support all clinical and research sequences of interest in brain and body imaging.
Here we propose to take this proof-of-concept to the next level and develop, implement, validate, and deploy the
first reconfigurable patient-adjustable (RPA) MRI coil technology tailored for imaging infants and young children.
Specifically, we propose to 1) Develop and validate a patient-adjustable rotating MRI transmit coil that eliminates
RF heating in children with cardiac and CNS implants, and 2) Develop age-optimized close-fitting head and body
receive arrays that integrate with the rotating coil and determine the range of imaging parameters that allow safe
deployment of the ensemble coil system in children with implants.
We are a multidisciplinary team including experts in MRI biophysics, instrumentation, and safety assessment,
clinicians with expertise and resources in pediatric radiology and pediatric surgery, as well as MRI vendors and
industry partners. If successful, our work brings state-of-the-art MRI accessible to children with implants. This
will allow methodical analysis of device parameters in emerging applications, improve our understanding of
existing indications, and brings unrestricted standard-of-care to pediatric patients with devices.
Public Health Relevance Statement
Narrative
Despite continuous advances, magnetic resonance imaging (MRI) remains largely inaccessible to patients who
have electronic implants. The problem is worse in children, for whom MR-conditional devices are not readily
available. Here we develop, validate, and deploy a novel MRI technology that allows ultra-fast and high-
resolution MRI to be safely performed in children with conductive implants regardless of the implant location.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
005436803
UEI
KG76WYENL5K1
Project Start Date
01-May-2023
Project End Date
31-March-2026
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$473,694
Direct Costs
$326,377
Indirect Costs
$147,317
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$473,694
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB034377-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB034377-02
Patents
No Patents information available for 5R01EB034377-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB034377-02
Clinical Studies
No Clinical Studies information available for 5R01EB034377-02
News and More
Related News Releases
No news release information available for 5R01EB034377-02
History
No Historical information available for 5R01EB034377-02
Similar Projects
No Similar Projects information available for 5R01EB034377-02